Puma Biotechnology at SABCS 2026
Dec 8–11, 2026 San Antonio, TX ~11k attendees Website
Puma Biotechnology at SABCS 2026 in San Antonio: Booth 209.
| Organization | SABCS 2026 Attendance |
|---|---|
Puma Biotechnology Los Angeles, CA | |
Markets NERLYNX (neratinib) for HER2-positive breast cancer and is testing alisertib with hormone therapy in HR+/HER2- metastatic breast cancer. | Booth Exhibiting at Booth 209 Wed, Dec 912:00pm–6:30pmThu, Dec 1012:00pm–6:30pmFri, Dec 1112:00pm–3:00pm |
Instantly find 20 buyers from Puma Biotechnology
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the San Antonio Breast Cancer Symposium, UT Health San Antonio or the American Association for Cancer Research. Organization details are derived from SABCS’s published exhibitor list. Submit a correction